Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior - Wikidata - awgldk - TriplyDB

Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior

Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior

http://www.wikidata.org/entity/Q35567406

about

Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer's disease.Debating clinical utility Impact of gene patents and licensing practices on access to genetic testing for Alzheimer disease.Genetic testing for Alzheimer's and long-term care insurance.GINA, genism, and civil rights The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop.Estimating and disclosing the risk of developing Alzheimer's disease: challenges, controversies and future directions Implementation and utilization of genetic testing in personalized medicine.Should we disclose amyloid imaging results to cognitively normal individuals?The role of disease perceptions and results sharing in psychological adaptation after genetic susceptibility testing: the REVEAL Study Emerging issues in public health genomics.The ghost in our genes: legal and ethical implications of epigenetics.Associations between self-referral and health behavior responses to genetic risk information.Returning individual research results: development of a cancer genetics education and risk communication protocol Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics Differences between African American and White research volunteers in their attitudes, beliefs and knowledge regarding genetic testing for Alzheimer's disease Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors Ethics and neuropsychiatric genetics: a review of major issues.Defining the spectrum of genome policy.Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease.Health insurance and the Genetic Information Nondiscrimination Act of 2008: implications for public health policy and practice.The future of direct-to-consumer clinical genetic tests.Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.Communicating genetic risk information for common disorders in the era of genomic medicine.Ethical issues of predictive genetic testing for diabetes.Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review.Desire for predictive testing for Alzheimer's disease and impact on advance care planning: a cross-sectional study.Engagement and communication among participants in the ClinSeq Genomic Sequencing Study.Would you want to know? Public attitudes on early diagnostic testing for Alzheimer's disease.The right not to know: the case of psychiatric disorders.Planning Ahead or Living a Day at a Time? A Family History of AD and Retirement Planning.Are guidelines needed for the diagnosis and management of incipient Alzheimer's disease and mild cognitive impairment?Expert consensus document: Mind the gaps—advancing research into short-term and long-term neuropsychological outcomes of youth sports-related concussions.Examining the Psychosocial Impact of Genetic Testing for Cardiomyopathies.

P2860

Q24234616-40E43840-08B2-4B5E-B9D6-0CF50068EDAC Q30585056-E2A1AF72-9755-49D9-B061-A13CE5F35DDB Q33423191-D46A70D6-F304-4A60-B986-002E53426494 Q33572491-1489489E-508D-43EB-A77C-8EF4654853E2 Q33832923-C0B46E1F-998C-409B-9BCF-C60BE65098F0 Q34032455-A2F113DE-FF94-4702-AA4C-2703D83FFD53 Q34097151-333DB2E8-F1AC-427F-A144-DF9B0327E33B Q34100723-81A4022E-5D30-4E0C-B780-5A0B0D2B9A2F Q34113976-56390541-FEC2-453C-A22F-564EFF7EE250 Q34135724-61DB81C4-DB51-4188-9F2C-B5537A374D60 Q34147916-0343E490-CFDE-4012-923E-533DE58406A5 Q34286140-E8A0BF83-A701-44E7-8017-EB7AC9F383E1 Q34332529-1BB586D6-18BA-4487-9C8F-8CBB786F09B5 Q34496940-85591190-6AF1-4402-A1B5-0F88747606C9 Q34555647-DC99160F-B868-4668-BE24-5FC0EBEB72AB Q35030090-A4757DC4-2D59-4D4C-BA8A-962A7F1717F2 Q35173889-85C7B4C7-2D6B-4466-B919-59A8B063EF43 Q35208130-92C71B90-4BE7-406D-AE59-97D1964EAF63 Q35316963-AA81FB99-3D3D-49C5-B274-3DF6B4694084 Q35570857-2F7C90C6-8710-4383-A09D-8C217E78D38B Q35621042-BCA900C2-2176-4E5E-8FA7-6707150E3276 Q35889850-D762B75B-03BD-4697-8EF9-5C77A4C86B5D Q35985180-9F621136-3524-48C3-A399-1D2A641CC78A Q36670498-AFB98A4A-6DF9-4DFF-AAF7-1BBBD61FC26C Q36790111-207A9495-EBDF-4600-899F-16B4B9D83A75 Q37029649-B865BF5E-2A3E-4429-98F1-918044D1A6EE Q37106491-066D74AE-3AEA-406A-A94E-EC0D57F0573E Q37148870-DADB1864-A448-4AD3-B400-2EBA4D6A3FE6 Q37170455-54A2F3B8-B3D3-4A1F-ABA5-98382647FB78 Q37389775-1C2A89AC-4AEE-41FB-BA01-3732FA07CC0C Q37404594-3860DE93-0B05-4358-980B-5B8477905A59 Q37406073-84C4F3F4-C235-459C-945B-2E61DB1A264C Q37498154-16CB01E0-3B2C-4733-91CF-A3FA021ACA56 Q37578172-00165F54-EE3C-4CB9-9356-C520897733D2 Q37690501-13BEEA90-7089-456B-80A3-B6556BF45FEB Q38770294-FF87F675-434B-45EC-9E0B-4B938F104703 Q38853005-DD3E9F5A-8363-4041-A6DE-7AD38F7403F8 Q41982613-779C56F4-1A8A-4C11-BA07-6476DEF47A43 Q45010732-95A3157F-EA94-4978-9153-F13A5B1DBEFD Q48113845-8454A6BE-5387-4DAD-B943-F0CF42344412

P2860

Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior

http://www.wikidata.org/entity/Q35567406

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior

@ast

Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior

@en

type

label

Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior

@ast

Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior

@en

prefLabel

Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior

@ast

Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior

@en

P1433

Q35567406-DD1EF5D4-1DC2-45C1-BE1C-8EC780B9D7AD

P1476

Q35567406-906AE0B5-2B01-4772-ADEF-026E04ABC12E

P2093

Q35567406-0D0C47C0-9806-449D-B61E-C0AF94CC75C2

Q35567406-642059A8-4372-481A-98B7-BC9644D9FAE4

Q35567406-96E67770-7AEC-4B65-B670-D67789E765A7

Q35567406-DF17F809-6DF8-4D74-BF3D-CD9AB29CA3C9

P2860

Q35567406-0CB32279-E83D-4088-B85C-689A84FF364B

Q35567406-206DDAFF-E17D-408F-BA1E-3FA3EEAFFCC7

Q35567406-25CB134F-C9E2-482C-9D1E-C7189A6A22E3

Q35567406-2BED9EC1-1594-4A3E-827E-3BD2EB3EA6F1

Q35567406-73F3C718-7B01-4F94-B773-12C50440F682

Q35567406-7C1108DF-09B8-4890-841D-4B153E84820E

Q35567406-7F81BD67-4C4C-45AA-A983-13C60E1BD1A9

Q35567406-BD95F719-F771-42A6-85ED-8D8FF47CFE7E

Q35567406-C49F232A-A4E8-4A61-91A8-4AC8C04A7728

Q35567406-F7753BCF-CD4B-4BC1-A6DA-4DACF79C9902

P304

Q35567406-676DC4C0-33BE-4253-ADF5-4EA812C421CB

P31

Q35567406-A3C1B6C3-4D04-489D-B44F-4F61BF2AA994

P356

Q35567406-6FF100C6-ACB0-4739-9B9C-B5E29845775D

P407

Q35567406-3827DD2A-F751-46D0-952F-A907FC3E5A28

P433

Q35567406-BAEB97C0-79F3-4527-A352-72F3866130C1

P478

Q35567406-CADCA852-317C-4238-9DA4-7E128B8B777F

P50

Q35567406-5A53CE50-7899-4C86-85F7-849AA41F9802

Q35567406-D5472CED-4398-4584-95B4-9FBB0E849FF6

P577

Q35567406-B0AA119B-0084-4B8E-A788-561EC04035B5

P5875

Q35567406-3A7ABB1B-FBD2-4029-A116-1A4D0221542A

P698

Q35567406-334BB295-CDFB-4582-BE5D-E658AED67CF3

P921

Q35567406-4EAD396A-08F0-4F86-8FC6-EA0FE4B57D68

P932

Q35567406-E27D0624-58AB-479E-A5C8-4866CE2206B8

P356

HLTHAFF.24.2.483

P1433

P1476

Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior

@en

P2093

Cathleen D Zick

http://www.w3.org/2001/XMLSchema#string

Charles J Mathews

http://www.w3.org/2001/XMLSchema#string

J Scott Roberts

http://www.w3.org/2001/XMLSchema#string

Robert J Pokorski

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer Disease in the US Population

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

Discrimination as a consequence of genetic testing.

Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial.

Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease.

Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study.

Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old?

Risk of dementia among white and African American relatives of patients with Alzheimer disease.

Genetic discrimination: perspectives of consumers.

Life insurance and breast cancer risk assessment: Adverse selection, genetic testing decisions, and discrimination

P304

483-490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1377/HLTHAFF.24.2.483

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Robert Cook-Deegan

Robert C. Green

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7976378

http://www.w3.org/2001/XMLSchema#string

P698

15757934

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1761120

http://www.w3.org/2001/XMLSchema#string